Composition
- Active ingredients
- AFLIBERCEPT 40MG/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA125387.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Eylea
- Active substance
- aflibercept
- Drug class
- Other antineoplastic agents, Antineovascularisation agents
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Regeneron Pharmaceuticals
- Status
- Prescription
- FDA approval
- 18 Nov 2011
- Application
- BLA125387-001
- RxCUI
- 1232155